lg 100268 has been researched along with Adenoma, beta-Cell in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ravnskjaer, K | 1 |
| Boergesen, M | 1 |
| Rubi, B | 1 |
| Larsen, JK | 1 |
| Nielsen, T | 1 |
| Fridriksson, J | 1 |
| Maechler, P | 1 |
| Mandrup, S | 1 |
1 other study available for lg 100268 and Adenoma, beta-Cell
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells.
Topics: Adenoviridae; Animals; Cell Line, Tumor; DNA Primers; Genes, Reporter; Glucose; Insulin; Insulin Sec | 2005 |